http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2610806-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9c105a60d79829ff725dee4fa418880 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2006-12-21^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77373425e313b3deed0bc49860ec284d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db0e5c9a85dcfd916d484f2bc81db11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4ef65815c8b857dd3d3221f34f2dc7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7219b4814e495fe6fbc1ae5c127284f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_653edb449fea72c63b9c877d8942673f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6808ea022438cc74f9279c81d99b8f08 |
| publicationDate | 2017-05-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2610806-T3 |
| titleOfInvention | Methods and combinations of markers for the detection of lung cancer predisposition |
| abstract | A method to aid in the diagnosis of a subject suspected of lung cancer, the method comprising the stages of: a. quantify in a test sample obtained from a subject, the amount of two or more biomarkers in a panel, wherein the quantified biomarkers are at least the anti-p53 antibody and the anti-TMP21 antibody; b. compare the amount of each biomarker in the panel with a predetermined cut-off point of said biomarker and assign a score for each biomarker based on said comparison; C. combine the assigned score for each biomarker determined in stage b to arrive at a total score of said subject; d. compare the total score determined in stage c with a predetermined total score; and e. determine whether said subject has a risk of lung cancer based on the total score; where a Distance from the Ideal ("DFI") of the biomarkers with respect to lung cancer is less than 0.4, and where the DFI is [(1-sensitivity) 2 + (1-specificity) 2] 1 / 2. |
| priorityDate | 2005-12-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 917 of 917.